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Hypogonadism, alopecia, diabetes mellitus, mental retardation, and extrapyramidal syndrome (also referenced as Woodhouse-Sakati
syndrome) is a rare autosomal recessive multisystemic disorder. We have identiﬁed a founder mutation consisting of a single base-
pair deletion in C2orf37 in eight families of Saudi origin. Three other loss-of-function mutations were subsequently discovered in
patients of different ethnicities. The gene encodes a nucleolar protein of unknown function, and the cellular phenotype observed in
patient lymphoblasts implicates a role for the nucleolus in the pathogenesis of this disease. Our ﬁndings expand the list of human
disorders linked to the nucleolus and further highlight the developmental and/or maintenance functions of this organelle.Introduction
Hypogonadism, alopecia, diabetes mellitus, mental retar-
dation, and extrapyramidal syndrome, also known as
Woodhouse-Sakati syndrome (WSS [MIM 241080]), is
a rare autosomal recessive disorder originally described
in a number of consanguineous Saudi families, but
which has recently been reported in other ethnicities as
well1–4 (Figures 1A and 1B). Additional manifestations
include sensorineural deafness, decreased signal intensity
in the basal ganglia, T-wave abnormalities, and depressed
insulin-like growth factor 1 (IGF-1) levels.5 The number
of organs involved clinically and the progressive nature
of their involvement suggest that the discovery of the
genetic defect underlying this syndrome will enhance
our understanding of the development and/or mainte-
nance of these organs. In this study, we used linkage
analysis followed by sequencing to uncover the gene
responsible for this multisystemic disorder. Our data
revealed a common founder mutation in C2orf37 as the
cause ofWSS in all the Saudi families we examined, includ-
ing the ones originally described by Woodhouse and
Sakati. Subsequent analysis of WSS patients from other
ethnicities identiﬁed three additional mutations in
C2orf37. We show that this gene encodes a previously
uncharacterized nucleolar protein and that nucleoli of
patient lymphoblasts display enhanced sensitivity to
transcriptional blockade.684 The American Journal of Human Genetics 83, 684–691, DecembMaterials and Methods
Patients
All patients or their legal guardians provided written and informed
consent according to a protocol approved by the institutional re-
view board of the institution wherein blood samples were taken,
in adherence to the Helsinki guidelines.
Linkage Analysis
Low-resolution whole-genome scan was initially performed with
the Human Marker Panel v.8a (Research Genetics). Multipoint
linkage analysis was performed with GeneHunter (v.1.2), and
a 100% penetrant autosomal recessive trait was assumed, with
a frequency of 0.0001 (rare disease) and equal allele frequency
for all microsatellite markers. This scan identiﬁed a region of
extended homozygosity on chromosome 2q between markers
D2S1399 and D2S434. Additional families were genotyped, and
ﬁne mapping subsequently reduced the critical region to 1.2 Mb;
the centromeric border was deﬁned by a dinucleotide repeat
polymorphism in intron 2 of the TLK1 gene (MIM 608438) and
the telomeric border by marker D2S326.
Mutation Detection
Primers were designed to ﬂank the coding regions of all genes in
the mapped interval, and direct sequencing was performed with
the dideoxy chain-termination method (Amersham ET Dye
Termination Sequencing Kit), with samples being processed on
a MegaBACE1000 (Molecular Dynamics). Sequence analysis was
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Figure 1. C2orf37 Mutations Are Responsible for Woodhouse-Sakati Syndrome
(A) WSS patient with dystonia and alopecia.
(B) One illustrative WSS pedigree showing multiple consanguinity loops.
(C) Haplotype analysis of Saudi WSS patients. Each column represents one of the 18 patients studied, and each row represents one of the
SNPs used for the analysis. Color codes specify the genotypes of each SNP as AA, BB, or AB, and the genetic distance of each SNP from
C2orf37 is listed to the right.
(D) Critical linkage interval obtained after fine mapping, with C2orf37 in red. The two major isoforms are shown as well, with open boxes
representing untranslated regions and shaded boxes representing the coding sequences (not drawn to scale). The ORFs are in-frame and
utilize the same stop codon. Chromatograms of the four mutations show control sequences on top, with mutations denoted by asterisks.
Arrowheads indicate location within the gene. RT-PCR analysis (using F1 and R1 primers) of a normal control and one WSS patient from (4)
reveals skipping of exon 10 in the latter.the text are based on Accession NM_025000.2. All primer
sequences are available from the authors upon request.
Haplotyping
For discovering the minimal interval of homozygosity for the
Saudi founder mutation, the haplotypes of 18 patients from
eight unrelated families were assessed with single-nucleotide
polymorphism (SNP)-speciﬁc primers. SNPs were spaced roughly
200 Kb apart for 3 Mb on either side of C2orf37. Calculating the
mutation’s age was as described.6
Characterization of Splice Isoforms
cDNA was synthesized from 1 mg of total lymphocyte RNA with
the First Strand Synthesis Kit (Promega) and random hexamers.
This was then PCR ampliﬁed with primers speciﬁc for exon 1a
and exon 14 or exon 1b and exon 14. The end product was
TA cloned (Invitrogen), and individual colonies were picked and
sequenced for establishing a catalog of splice variants.The AmericanGFP-Fusion and Overexpression Constructs
For the GFP-fusion experiment, a full-length open reading frame
(ORF) of the b-isoform was subcloned into peGFP-C1 (Clontech)
and then sequenced bidirectionally for ensuring the absence
of PCR artifacts. For overexpression studies without the use of a
fusion tag, the same ORF was subcloned into pAsc (a kind gift
from Khalid Abu Khabar), allowing expression of exogenous
protein under a cytomegalovirus promoter.
Cell Culture
HEK293 cells were maintained under standard conditions in
Dulbecco’s modiﬁed Eagle’s medium supplemented with 10%
fetal bovine serum, 100 units/ml of penicillin/streptomycin, and
L-glutamine. Epstein-Barr virus (EBV)-transformed lymphoblasts
were maintained in RPMI supplemented with 20% fetal bovine
serum and 200 units/ml of penicillin/streptomycin. For transfec-
tion experiments, HEK293 cells were cultured in six-well dishes
on coverslips coated with Poly-L-Lysine (Sigma) and transfectedJournal of Human Genetics 83, 684–691, December 12, 2008 685
with SuperFect (QIAGEN) according to the manufacturers’
instructions.
Real-Time Reverse Transcriptase-Polymerase Chain
Reaction
A suite of ﬁrst-strand cDNA from 48 adult, healthy human tissues
was purchased from Origene. Primers speciﬁcally interrogated
the abundance of exon 1a versus exon 1b cDNA. Reactions
were performed in a LightCycler (Roche), and PCR products
were subsequently assessed via melt-curve analysis and gel electro-
phoresis.
Antibody Production
Production of the C2orf37 rabbit polyclonal antibody was out-
sourced to Abgent. The antigenic sequence FNLLDDDPEQETFKI
corresponds to amino acids 412–426 of the protein (Accession
NP_079276.2), and the antibody was delivered after afﬁnity-
column puriﬁcation along with the synthetic antigen.
Immunohistochemistry
Mouse embryo tissue slides were purchased from Zyagen. After an-
tigen retrieval, slides were processed with the streptavidin-biotin
peroxidase technique, and diaminobenzidine (DAB) was used as
chromogen. The sections were incubated overnight in a 1:1000
dilution of anti-C2orf37, and the Dako Envision Plus System kit
was used as the secondary detection system, with DAB as chromo-
gen. Endogenous peroxidase activity was quenched with 3%
hydrogen peroxidase in methanol. Endogenous biotin was
blocked, and all slides were counterstained with hematoxylin,
dehydrated, cleared, and coverslipped with premount. A cell-line
block of HEK293 cells served as a positive control. Two types of
negative controls were used: The ﬁrst was the exclusion of the
primary antibody, and the second was a peptide competition
assay. For the latter, anti-C2orf37 was preincubated with the
peptide antigen (Abgent) at a 1:2 ratio (w/w) for 1 hr at room
temperature, prior to staining.
Tissue Section In Situ Hybridization
RNA extracted from ﬂash-frozen adult mouse liver (RNeasy Mini
Kit, QIAGEN) was used as template for synthesizing two PCR
products speciﬁc for 4833418A01Rik, the C2orf37mouse ortholog
(SuperScript One-Step RT-PCR, Invitrogen). The ﬁrst of these
PCR products corresponded to an 871 base pair (bp) fragment
beginning at c.46 (Accession AK160679.1), and the second corre-
sponded to an 894 bp fragment starting at c.1076. PCR primers
were tagged with T7 or SP6 sequences. Sense and antisense digox-
ygenin-labeled RNA probes were prepared with the MaxiScript Kit
(Ambion) and Roche’s DIG RNA Labeling Mix. Mouse embryo
tissue slides from Zyagen were heated to 45C (30 min), allowed
to cool to room temperature, twice dewaxed in xylene (15 min
each), and then rehydrated. All subsequent steps were performed
with the InsituPro VSi (Intavis) in accordance with a manufac-
turer-recommended protocol. Samples were twice permeabilized
with proteinase K (10 mg/ml) at 37C for 10 min each, hybridized
to the probe for 12 hr at 65C, and incubated with alkaline-
phosphatase-coupled digoxygenin antibody (Roche) at room
temperature for 4 hr. Full details are available from the authors
upon request. Slides were ﬁnally incubated in BM Purple (Roche)
until appropriate color development.686 The American Journal of Human Genetics 83, 684–691, DecembImmunoﬂuorescence
HEK293 cells grown on coverslips were ﬁxed with prewarmed
3.6% formaldehyde, then permeabilized with 0.5% Triton X-100
(Sigma). Mouse monoclonal anti-B23 was purchased from Abcam
(ab10530). After 1 hr incubation with primary antibody at room
temperature, cells were incubated for another hour in rhodamine-
or ﬂourescein-labeled goat anti-mouse or anti-rabbit IgG (Pierce),
then observed under a ﬂuorescent microscope (Zeis). Lympho-
blasts were treated as above, except that all incubations were
carried out in suspension, and cells were centrifuged at 3000 g
for 2 min between steps. The peptide competition assay was
performed as described for immunohistochemistry.
Drug Treatment
For the selective inhibition of RNA polymerase I-catalyzed
transcription, HEK293 cells and lymphoblasts were treated with
0.05 mg/ml actinomycin D (Sigma) for 3 hr prior to ﬁxation. For
full inhibition of cellular transcription, this was increased to
10 mg/ml.
Gene-Expression Proﬁling
Total RNA was extracted from two unrelated normal control lym-
phoblast cell lines and three unrelated patient lymphoblast cell
lines with standard protocols. Sample handling, cDNA synthesis,
cRNA labeling and synthesis, hybridization, washing and
scanning of chips, and all related quality controls were performed
according to manufacturer’s instructions (Affymetrix). Two
replicates of each sample were run on Affymetrix GeneChip
Human Genome U133 Plus 2.0 Arrays. Statistical analyses were
performed with MATLAB (The Math Works) and the PARTEK
Genomics Suite (Partek software v.6.3, Partek). Signiﬁcantly
modulated genes were deﬁned as those with an absolute fold
change >2 and an unadjusted p value <0.006.
Results
Mutations in C2orf37 Cause WSS
A genome-wide linkage analysis on three affected siblings
from one of the original Saudi families identiﬁed an
extended autozygous region encompassing chromosome
2q22.3–2q35. Inclusion of another family with four
affected siblings conﬁrmed the homozygosity and yielded
a maximum multipoint LOD score of 6.13 from markers
D2S2284 to D2S1791. Fine mapping further narrowed
the critical region to 1.2 Mb; the centromeric border was
deﬁned by a dinucleotide repeat polymorphism in intron
2 of the TLK1 gene and the telomeric border by marker
D2S326. This region contains a total of 13 genes and
pseudogenes, both known and predicted (Figure 1D).
Sequencing of a hypothetical gene, C2orf37, revealed the
only mutation we found within this interval: a 1 bp
deletion that fully segregated with the phenotype (c.436
delC; see Methods for numbering scheme) (Figure 1D).
The same mutation was uncovered in six additional Saudi
families but was not found in 274 Saudi control chromo-
somes. To address doubts that C2orf37 might simply be
a pseudogene segregating perfectly with the disease locus,
we sequenced all putative coding segments of this gene iner 12, 2008
at least 184 normal Saudi chromosomes, and no truncating
mutations were found. SNP-based haplotype analysis con-
ﬁrmed that this is a founder mutation, with a haplotype
interval of 1.1 Mb shared between 18 Saudi patients
(Figure 1C). Calculations based on a simpliﬁed likelihood
algorithm6 suggest a maximal probability that this muta-
tion arose approximately 55 generations ago.
Analysis of this gene has revealed extreme splicing
variability, and, from lymphocytes alone, we have isolated
at least 30 different isoforms that vary greatly in abun-
dance (data not shown). Our common mutation resides
in exon 4 but is not likely to be pathogenic for every splice
form. We have identiﬁed at least two major isoforms of
roughly equal abundance, each bearing a different initia-
tion site. In the ﬁrst of these (henceforth referred to as
the a-isoform), the 1 bp deletion is predicted to lie in the
50UTR and so is unlikely to be pathogenic, whereas in the
other (which we here refer to as the b-isoform), it resides
within the ORF and is predicted to cause a frameshift
(p.Ala147HisfsX9; Accession NP_079276.2) (Figure 1D).
Subsequent analysis of WSS patients from other ethnicities
revealed three additional mutations in this gene. A
sporadic patient of Eastern European descent2 harbored
a 1 bp deletion that again predicts a frameshift in the
b-isoform only (c.50 delC). The other two mutations affect
splice donor sites: An Indian family with three affected
individuals1 carried a c.1422þ5G > T mutation, whereas
two affected siblings of Middle Eastern origin4 displayed
the mutation c.1091þ6T > G. These splice-site mutations
are predicted to be pathogenic for both major transcripts.
The latter (Middle Eastern) mutation was conﬁrmed to
result in the skipping of exon 10, leading to a frameshift
(Figure 1D). The Indian mutation changes the GTGAGT
consensus-donor sequence to GTGATT and is predicted
to result in a dramatic drop in splicing efﬁciency (from
0.95 to 0.06, according to the Berkeley Drosophila Genome
Project, and from 0.81 to 0.0, according to the NetGene2
Server). All patients from all ethnicities were homozygous
for their respective mutations. As a further check, ethni-
cally matched normal controls were screened for each of
the three non-Saudi mutations: The Middle Eastern
mutation was screened against 250, the Slovenian against
210, and the Indian against 196 control chromosomes.
As with the Saudi mutation, none of the controls was
found to be a carrier. These independent mutations
provide compelling evidence that aberrations in C2orf37
underlie this syndrome.
C2orf37 Encodes a Nucleolar Protein
Virtually nothing is known aboutC2orf37 or the proteins it
encodes. The b-isoform encompasses the longest possible
ORF, predicting a 520 amino acid protein that does not
contain any recognized domain or localization signal and
that shares no signiﬁcant homology with other proteins.
This putative amino acid sequence is well conserved across
species, however, with orthologs (also hypothetical)
present in the mouse, rat, chimpanzee, cow, fowl, andThe Americanother higher animals (expect value ¼ 0.0). In humans,
the predicted peptide for the a-isoform is identical to the
last 240 residues of the b-isoform protein, given that the
two ORFs are in-frame and utilize the same stop codon
(Figure 1D). Real-time RT-PCR analysis of various adult
human tissues revealed low ubiquitous expression of
both isoforms in all tissues examined (data not shown).
With an aim to further characterize the proteins, we raised
a polyclonal antibody against a synthetic peptide repre-
senting a hydrophilic stretch of 15 amino acids encoded
by exon 12. This stretch is shared by the putative peptides
of both the a-isoform and b-isoform. Immunohisto-
chemistry using this antibody revealed nearly ubiquitous
nucleolar expression for C2orf37 in mouse embryos, with
regions of enhanced staining in the brain, liver, and skin
tissues (Figures 2A–2C). There was no appreciable staining
of islet cells at the developmental stages examined, how-
ever (E16.5 mouse embryo and adult human pancreas).
Preincubating the antibody with the peptide antigen
abrogated the nucleolar staining and thus conﬁrmed
speciﬁcity of the signal (Figure 3). As a companion experi-
ment, we also performed in situ hybridization on mouse
embryo sections to assess the RNA expression proﬁle for
4833418A01Rik, the mouse ortholog of C2orf37. Two sense
and two antisense probes were used for this purpose. The
staining patterns for both antisense probes were analogous
to the results obtained through immunohistochemistry,
with 4833418A01Rik transcription most evident in the
brain, liver, and skin tissues (Figures 2D–2F). The intensity
of staining in the brain was comparatively weak when eval-
uated against the other two tissues, although this is in line
with the data provided by the Allen Brain Atlas for this
gene. As a negative control, the two sense probes generated
only nonspeciﬁc staining, as expected (data not shown).
These RNA and protein staining patterns are biologically
relevant given that WSS patients manifest CNS abnormal-
ities, alopecia, and low IGF-1 (liver hormone).5
Given the lack of any conserved domains or clear local-
ization signals, we set out to assess the cellular activity of
C2orf37 through the use of a GFP-fusion construct
transfected into HEK293 cells. Intriguingly, expression of
the fusion protein resulted in disruption of the nuclear
membrane and the aggregation of the fusion protein into
a large globular structure displacing the nucleus, probably
an artifact indicative of toxicity (data not shown). In lieu of
meaningful GFP-fusion data, the two major isoforms of
C2orf37 were exogenously expressed in HEK293 without
fusion to any tags and then detected with our antibody.
Overexpression of both a-protein and b-protein isoforms
demonstrated nucleolar localization, in line with our
immunohistochemistry ﬁndings (Figures 4A–4C). We
also explored the localization of the endogenous
protein in untransfected cells, and here, too, our antibody
speciﬁcally recognized nucleoli in accordance with our
immunohistochemistry data. This was conﬁrmed through
colocalization of the endogenous C2orf37 with B23 (nucle-
ophosmin), a knownmarker of the granular component ofJournal of Human Genetics 83, 684–691, December 12, 2008 687
Figure 2. Immunohistochemistry and In Situ Hybridization on Mouse Embryonic Tissues
Intense nucleolar staining of hepatocytes (heart tissue is visible in the upper right corner) at E16.5 (A), brain cells at E12.5 (B), and
different layers of skin including a hair follicle (inset) at E14.5 (C). Bottom panels present in situ hybridization patterns observed for
liver tissue at E13.5 (D), cortex of the brain at E15.5 (E), and skin at E15.5 (F).the nucleolus7 (Figures 4D–4F). Again, preincubation of
the antibody with the peptide antigen resulted in complete
loss of this staining, whereas, as a positive control, the
GFP-fusion protein in transfected HEK293 cells was found
to colocalize perfectly with anti-C2orf37 staining (data not
shown). These results further veriﬁed antibody speciﬁcity.
Nucleoli in Patient Lymphoblasts Have Enhanced
Sensitivity to Transcriptional Blockade
To further interrogate the function of C2orf37, we sub-
jected HEK293 cells to low and high doses of actinomycin
D, a powerful inhibitor of transcription. The low dose selec-
tively blocks the nucleolar RNA polymerase I only, whereas688 The American Journal of Human Genetics 83, 684–691, Decembthe high dose impedes all transcriptional activity in the
cell.8 We discerned that at the lower dosage, C2orf37
mostly retains its nucleolar compartmentalization, whereas
B23, involved in ribosome biogenesis among other func-
tions, diffuses fully into the nucleoplasm. Surprisingly,
although the higher dosage does induce C2orf37 transloca-
tion to the nucleoplasm, a minority of cells continues to
retain it in the nucleolus (Figure 5). Our ﬁndings hence
suggest that the nucleolar localization of C2orf37 is only
partially dependant on active transcription.9
To assess the effects of the founder mutation, we
compared lymphoblasts from Saudi patients and con-
trols and found that patient lymphoblasts consistentlyFigure 3. Nucleolar Staining of C2orf37 Is Specific
(A) Immunohistochemistry on paraffin sections of a HEK293 cell block showing strong nucleolar and weak cytoplasmic staining.
(B) Nucleolar but not cytoplasmic staining is abrogated when the slide is incubated with the peptide antigen prior to staining with
C2orf37 antibody.
(C) Buffer negative control, with the primary antibody excluded.er 12, 2008
demonstrated enhanced sensitivity to the transcriptional
blockade induced by low actinomycin D concentration.
This was evident from the loss of nucleolar staining
of both B23 and C2orf37 in a majority of actinomycin
D-treated patient lymphoblasts, in contrast to an opposite
trend observed in control cells (Figures 4G–4L).
Discussion
In this study we have shown that mutations in C2orf37
cause the hypogonadism, alopecia, diabetes mellitus, men-
tal retardation, and extrapyramidal syndrome described by
Woodhouse and Sakati in 1983. As can be inferred from the
pleiotropic nature of the disorder, the expression proﬁle of
C2orf37 is wide but relevant to the clinical manifestations,
given that we have demonstrated pockets of increased ex-
pression in the brain, liver, and skin. Weak expression has
also been seen in seminiferous tubules, but no convincing
expression could be seen in islet cells. The latter could be
attributed to the limited number of developmental stages
examined immunohistochemically (E16.5 mouse embryo
and adult human), although in situ analysis of multiple
embryo stages demonstrated similar absence of islet cell
staining. Despite the apparent lack of any clear localization
signal, the C2orf37 proteins that we tested have consis-
tently been detected in the nucleoli. Our hypothesis
Figure 4. Both Major Isoforms of
C2orf37 Localize to the Nucleolus in
Tissue Culture
(A–C) Overexpression of the b-isoform
protein from a cloned expression construct
results in nucleolar localization of the
peptide in HEK293 cells. The same pattern
appears for the a-isoform.
(D–F) Endogenous C2orf37 colocalizes with
B23, a nucleolar marker, in lymphoblasts.
(G–L) C2orf37 and B23 remain largely
nucleolar after low-dose actinomycin D
treatment of control lymphoblasts (G–I),
but largely nucleoplasmic in patient
lymphoblasts (J–L), where their colocaliza-
tion is partially lost (indicated by arrow-
head).
that a nucleolar defect may underlie
the pathogenesis of WSS was further
substantiated by the nucleolar hyper-
sensitivity of patient lymphoblasts
to transcriptional blockade. Similar
hypersensitivity to actinomycin D
has been recently reported in Dia-
mond-Blackfan anemia, a distinct
but similarly pleiotropic autosomal
recessive disorder.10 Although it may
be tempting to speculate that defec-
tive ribosome biogenesis is the pathogenic mechanism in
WSS, this cellular phenotype has to be viewed in the con-
text that long-term inhibition of RNA polymerase I blocks
not only rRNA transcription, but subsequently the assem-
bly of the nucleolus itself by impeding the fusion of
prenucleolar bodies (PNBs) and the nucleolar organizer
regions (NORs).8 Therefore, actinomycin D may be un-
masking an assembly defect, and so we cannot discard
the possibility that other nucleolar functions, which
include regulation of cell cycle, cellular aging, signal-
recognition-particle biosynthesis, small-RNA processing,
mRNA transport, and even apoptosis,11,12 may underlie
the pathogenesis of WSS. Indeed, when we compare the
expression signature of control and patient lymphoblasts,
we observe signiﬁcant differential expression of genes
involved in apoptosis (data not shown). Very recently,
Nousbeck et al. reported in this journal that a syndrome
characterized by alopecia, neurological defects, and endo-
crinopathy is caused by decreased expression of RBM28,
a nucleolar protein associated with ribosome biogenesis.13
Although that syndrome and WSS are distinguishable
clinically, our implication of a nucleolar protein in the
pathogenesis of WSS strongly suggests that the clinical
similarity between the two syndromes may reﬂect an
overlapping molecular defect. Given the pleiotropic
nature of WSS, analysis of C2orf37 promises to shed light
on the ill-deﬁned role of the nucleolus in the developmentThe American Journal of Human Genetics 83, 684–691, December 12, 2008 689
Figure 5. Nucleolar Localization of C2orf37 in HEK293 Cells Is Less Dependent than B23 on Active Transcription
(A–E) C2orf37 and B23 colocalize at the nucleolus under normal conditions in HEK293 cells.
(F–J) Low-dose actinomycin D treatment results in full displacement of B23 but only partial displacement of C2orf37 to the nucleoplasm
(arrowheads point to foci of retained nucleolar localization).
(K–O) High-dose actinomycin D results in a similar but more potent effect, given that less foci of retained C2orf37 nucleolar localization
can be seen.and/or maintenance of multiple key organs such as the
liver and brain.
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